Published in Blood Weekly, November 6th, 2008
"Using a four-stage differentiation protocol which contains neuronal differentiation factor and WC-conversion reagent-nicotinamide, the potential of human MSCs to differentiate into IPCs...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.